Opal, S M <br/><br/>
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.  [electronic resource] 

 -  Critical care medicine  Jul 1997 
 - 1115-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Standard No.: </label>10.1097/00003246-199707000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Interleukin 1 Receptor Antagonist Protein<br/>Male<br/>Middle Aged<br/>Receptors, Interleukin-1--antagonists & inhibitors<br/>Recombinant Proteins--therapeutic use<br/>Sepsis--drug therapy<br/>Shock, Septic--drug therapy<br/>Sialoglycoproteins--therapeutic use<br/>Survival Analysis